Pfizer buys into decentralized cooperative to accelerate R&D in human longevity
The biggest of Big Pharma is turning over a new, edgier leaf, proposing to spend $500,000 to join a new cooperative, known as VitaDAO, for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
